DeepMind AlphaFold 3 Pioneers AI-Designed Cancer Drug in Clinical Trial: AI Pharma's Qualitative Leap from Prediction to Creation
DeepMind's AlphaFold 3 has achieved a milestone with its first AI-designed cancer drug DM-301 entering Phase I clinical trials, marking the transition of AI in drug discovery from auxiliary tool to independent creator.